Menu
HERCEPTIN-600-MG-5-ML-S.C

HERCEPTIN 600 MG/ 5 ML S.C.

206 412 руб.

Артикул: 30219.

206 412 руб.

Выбрать количество
Выбрать дозировку
Очистить
Стоимость
Сравнить

ПОКАЗАНИЯ К ПРИМЕНЕНИЮ

Breast cancerMetastatic breast cancerHerceptin is indicated for the treatment of adult patients with HER2 positive metastatic breast cancer (MBC): — as monotherapy for the treatment of those patients who have received at least two chemotherapy regimens for their metastatic disease. Prior chemotherapy must have included at least an anthracycline and a taxane unless patients are unsuitable for these treatments. Hormone receptor positive patients must also have failed hormonal therapy, unless patients are unsuitable for these treatments. — in combination with paclitaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease and for whom an anthracycline is not suitable. — in combination with docetaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease. — in combination with an aromatase inhibitor for the treatment of postmenopausal patients with hormone-receptor positive MBC, not previously treated with trastuzumab.Early breast cancerHerceptin is indicated for the treatment of adult patients with HER2 positive early breast cancer (EBC). — following surgery, chemotherapy (neoadjuvant or adjuvant) and radiotherapy (if applicable) . — following adjuvant chemotherapy with doxorubicin and cyclophosphamide, in combination with paclitaxel or docetaxel. — in combination with adjuvant chemotherapy consisting of docetaxel and carboplatin. — in combination with neoadjuvant chemotherapy followed by adjuvant Herceptin therapy, for locally advanced (including inflammatory) disease or tumours > 2 cm in diameterHerceptin should only be used in patients with metastatic or early breast cancer whose tumours have either HER2 overexpression or HER2 gene amplification as determined by an accurate and validated assay .

  • Действующее вещество : TRASTUZUMAB
  • Производитель : HOFFMANN LA ROCHE LTD, SWITZERLAND
  • Форма упаковки : VIAL 6 ML GLASS TYPE I
  • Срок годности : 18 мес.
  • Таможня : Без ограничений
  • Класс доставки : Авиапочта, до 5 дней
  • Информация о препарате от Минздрава Израиля : http://www.old.health.gov.il/units/pharmacy/trufot/PerutTrufa.asp?Reg_Number=154 80 34547 00&safa=e
  • По рецепту : Да

ПРЕПАРАТЫ С ТЕМ ЖЕ ДЕЙСТВУЮЩИМ ВЕЩЕСТВОМ

Описание товара

В Израиле В России
Герцептин

Метастазирующий рак молочной железы с опухолевой гиперэкспрессией HER2 (монотерапия после одной или более схем химиотерапии, в комбинации с паклитакселом в случае отсутствия предшествующей химиотерапии).

Герцептин

Additional Information

Количество в упаковке

1 X VIAL